Biglycan regulates the expression of EGF receptors through EGF signaling pathways in human articular chondrocytes

REFERENCES

• Iozzo, R.V. (1998). Matrix proteoglycans: From molecular design to cellular function. Ann. Rev. Biochem. 67:609–652.
   PubMed Web of Science ®Google Scholar
• Iozzo, R.V. (1999). The biology of the small leucine-rich proteoglycans. Functional network of interactive proteins. J. Biol. Chem. 274:18843–18846.
   PubMed Web of Science ®Google Scholar
• Roughley, P.J. (2006). The structure and function of cartilage proteoglycans. Eur. Cells Mat. 12:92–101.
   PubMed Web of Science ®Google Scholar
• Wiberg, C., Klatt, A.R., Wagener, R., Paulsson, M., Bateman, J.F., Heinegard, D., and Morgelin, M. (2003). Complexes of matrilin-1 and biglycan or decorin connect collagen VI microfibrils to both collagen II and aggrecan. J. Biol. Chem. 278:37698–37704.
   PubMed Web of Science ®Google Scholar
• Young, M.F., Bi, Y., Ameye, L., and Chen, X.-D. (2002). Biglycan knockout mice: New models for musculoskeletal diseases. Glycoconjugate J. 19:257–262.
   PubMed Web of Science ®Google Scholar
• Ameye, L.G., Deberg, M., Oliveira, M., Labasse, A., Aeschlimann, J.M., and Henrotin, Y. (2007). The chemical biomarkers C2C, Coll2-1, and Coll2-1NO2 provide complementary information on type II collagen catabolism in healthy and osteoarthritic mice. Arthritis Rheum. 56:3336–3346.
   PubMed Web of Science ®Google Scholar
• Ameye, L., and Young, M.F. (2002). Mice deficient in small leucine-rich proteoglycans: Novel in vivo models for osteoporosis, osteoarthritis, Ehlers-Danlos syndrome, muscular dystrophy, and corneal diseases. Glycobiology 12:107R–116R.
   PubMed Web of Science ®Google Scholar
• Corsi, A., Xu, T., Chen, X.D., Boyde, A., Liang, J., Mankani, M., Sommer, B., Iozzo, R.V., Eichstetter, I., Robey, P.G., Bianco, P., and Young, M.F. (2002). Phenotypic effects of biglycan deficiency are linked to collagen fibril abnormalities, are synergized by decorin deficiency, and mimic Ehlers-Danlos-like changes in bone and other connective tissues. J. Bone Min. Res. 17:1180–1189.
   PubMed Web of Science ®Google Scholar
• Le Graverand, M.P., Eggerer, J., Vignon, E., Otterness, I.G., Barclay, L., and Hart, D.A. (2002). Assessment of specific mRNA levels in cartilage regions in a lapine model of osteoarthritis. J. Orthop. Res. 20:535–544.
   Google Scholar
• Liu, W., Burton-Wurster, N., Glant, T.T., Tashman, S., Sumner, R.D., Kamath, R., Lust, G., Kimura, J., and Cs‐Szabo, G. (2003). Spontaneous and experimental osteoarthritis in dog: Similarities and differences in proteoglycan levels. J. Orthop. Res. 21:730–737.
   PubMed Web of Science ®Google Scholar
• Cs-Szabo, G., Ragasa, D., Berger, R.A., and Kuettner, K.E. (2002). Small proteoglycans in knee and ankle cartilage. In Many Faces of Osteoarthritis, V. Hascall and K.E. Kuettner ( eds.) pp. 369–372. Basel, Switzerland: Birkhauser Verlag AG.
   Google Scholar
• Poole, A.R., Rosenberg, L.C., Reiner, A., Ionescu, M., Bogoch, E., and Roughley, P.J. (1990). Contents and distributions of the proteoglycans decorin and biglycan in normal and osteoarthritic human articular cartilage. J. Orthop. Res. 14:681–689.
   Google Scholar
• Cs-Szabo, G., Melching, L.I., Roughley, P.J., and Glant, T.T. (1997). Changes in messenger RNA and protein levels of proteoglycans and link protein in human osteoarthritic cartilage samples. Arthritis Rheum. 40:1037–1045.
   PubMed Web of Science ®Google Scholar
• Ribault, D., Khatib, A.-M., Panasyuk, A., Barbara, A., Bouizar, Z., and Mitrovic, R.D. (1997). Mitogeninc and metabolic actions of epidermal growth factor on rat articular chondrocytes: Modulation by fetal calf serum, transforming growth factor-β, and tyrphostin. Arch. Biochem. Biophys. 337:149–158.
   PubMed Web of Science ®Google Scholar
• Schmal, H., Mehlhorn, A.T., Zwingmann, J., Muller, C.A., Stark, G.B., and Sudkamp, N.P. (2005). Stimulation of chondrocytes in vitro by gene transfer with plasmids coding for epidermal growth factor (hEGF) and basic fibroblast growth factor (bFGF). Cytotherapy 7:292–300.
   PubMed Web of Science ®Google Scholar
• Marshall, C.J. (1995). Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation. Cell 80:179–185.
   PubMed Web of Science ®Google Scholar
• Santos, S.D.M., Verveer, P.J., and Bastiaens, P.I.H. (2007). Growth factor-induced MAPK network topology shapes Erk response determining PC-12 cell fate. Nat. Cell Biol. 9:324–330, S1–S6.
   PubMed Web of Science ®Google Scholar
• Green, L.A., and Tischler, A.S. (1976). Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl. Acad. Sci. USA 73:2424–2428.
   PubMed Web of Science ®Google Scholar
• Liang, Y., Haring, M., Roughley, P.J., Margolis, R.K., and Margolis, R.U. (1997). Glypican and biglycan in the nuclei of neurons and glioma cells: Presence of functional nuclear localization signals and dynamic changes in glypican during the cell cycle. J. Cell. Biol. 139:851–864.
   PubMed Web of Science ®Google Scholar
• Moscatello, D.K., Santra, M., Mann, D.M., McQuillan, D.J., Wong, A.J., and Iozzo, R.V. (1998). Decorin suppresses tumor cell growth by activating the epidermal growth factor receptor. J. Clin. Invest. 101:406–412.
   PubMed Web of Science ®Google Scholar
• Kresse, H., and Schonherr, E. (2001). Proteoglycans of the extracellular matrix and growth control. J. Cell. Physiol. 189:266–274.
   PubMed Web of Science ®Google Scholar
• Cs-Szabo, G. (2007). Small leucine-rich proteoglycans of the cartilage and their potential role in tissue repair. Osteoarthr. Cartil. 15(Suppl. 2):B30.
   Google Scholar
• Shiraha, H., Gupta, K., Drabik, K., and Wells, A. (2000). Aging fibroblasts present reduced epidermal growth factor (EGF) responsiveness due to preferential loss of EGF receptors. J. Biol. Chem. 275:19343–19351.
   PubMed Web of Science ®Google Scholar
• Kinoshita, A., Takigawa, M., and Suzuki, F. (1992). Demonstration of receptors for epidermal growth factor on cultured rabbit chondrocytes and regulation of their expression by various growth and differentiation factors. Biochem. Biophys. Res. Comm. 183:14–20.
   PubMed Web of Science ®Google Scholar
• Farahat, M.N., Yanni, G., Poston, R., and Panayi, G.S. (1993). Cytokine expression in synovial membranes of patients with rheumatoid arthritis and osteoarthritis. Ann. Rheum. Dis. 52:870–875.
   PubMed Web of Science ®Google Scholar
• Collins, D.H. (1949). Osteoarthritis [Chapter V]. In The Pathology of Articular and Spinal Diseases. London, UK: E. Arnold and Co., 74–115.
   Google Scholar
• Muehleman, C., Bareither, D., Huch, K., Cole, A.A., and Kuettner, K.E. (1997). Prevalence of degenerative morphological changes in the joints of the lower extremity. Osteoarthr. Cartil. 5:23–37.
   PubMed Web of Science ®Google Scholar
• Kuettner, K.E., Pauli, B.D., Gal, G., Memoli, V.A., and Schenk, R.K. (1982) Synthesis of cartilage matrix by mammalian chondrocytes in vitro. I. Isolation, culture characteristics, and morphology. J. Cell. Biol. 93:743–750.
   PubMed Web of Science ®Google Scholar
• Pfaffl, M.W. (2001). A new mathematical model for relative quantification in real-time RT-PCR. Nucl. Acids Res. 29:e45.
   PubMed Web of Science ®Google Scholar
• Gotte, M., Sofeu Feugaing, D.D., and Kresse, H. (2004). Biglycan is internalized via a chlorpromazine-sensitive route. Cell. Mol. Biol. Lett. 9:475–481.
   PubMed Web of Science ®Google Scholar
• Goldring, M.B., and Goldring, S. (2007). Osteoarthritis. [Review]. J. Cell. Physiol. 213:626–634.
   PubMed Web of Science ®Google Scholar
• Goldring, M.B. (2000). The role of the chondrocyte in osteoarthritis. [Review]. Arthritis Rheum. 43:1916–1926.
   PubMed Web of Science ®Google Scholar
• Klooster, A.R., and Bernier, S.M. (2005). Tumor necrosis factor alpha and epidermal growth factor act additively to inhibit matrix gene expression by chondrocytes. Arthritis Res. Ther. 7:R127–R138.
   PubMed Web of Science ®Google Scholar
• Bi, Y., Nielsen, K.L., Kilts, T.M., Yoon, A., Karsdal, M., Wimer, H.F., Greenfield, E.M., Heegaard, A.M., and Young, M.F. (2006). Biglycan deficiency increases osteoclast differentiation and activity due to defective osteoblasts. Bone 38:778–786.
   PubMed Web of Science ®Google Scholar
• Woodard, J.C., Donovan, G.A., and Fisher, L.W. (1997). Pathogenesis of vitamin (A and D)-induced premature growth-plate closure in calves. Bone 21:171–182.
   PubMed Web of Science ®Google Scholar
• Hayashi, Y., Liu, C.-Y., Jester, J.J., Hayashi, M., Wang, I.-J., Funderburgh, J.L., Saika, S., Roughley, P.J., Kao, C.W.-C., and Kao, W.W.-Y. (2005). Excess biglycan causes eyelid malformation by perturbing muscle development and TGF‐alpha signaling. Dev. Biol. 277:222–234.
   PubMed Web of Science ®Google Scholar
• Mio, K., Kirkham, J., and Bonass, W.A. (2007). Possible role of extracellular signal-regulated kinase pathway in regulation of Sox9 mRNA expression in chondrocytes under hydrostatic pressure. J. Biosci. Bioeng. 104:506–509.
   PubMed Web of Science ®Google Scholar
• Fanning, P.J., Emkey, G., Smith, R.J., Grodzinsky, A.J., Szasz, N., and Trippel, S.B. (2003). Mechanical regulation of mitogen-activated protein kinase signaling in articular chondoryctes. J. Biol. Chem. 278:50940–50948.
   PubMed Web of Science ®Google Scholar
• Zimmermann, S., and Moelling, K. (1999). Phosphorylation and regulation of Raf by Akt. Science 286:1741–1744.
   PubMed Web of Science ®Google Scholar
• Kajanne, R., Miettinen, P., Mehlem, A., Leivonen, S.-K., Birrer, M., Foschi, M., Kahari, V.-M., and Leppa, S. (2007). EGF-R regulates MMP function in fibroblasts through MAPK and AP-1 pathways. J. Cell. Physiol. 212:489–497.
   PubMed Web of Science ®Google Scholar